INVO Fertility, Inc.
IVF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7 | $3 | $1 | $4 |
| % Growth | 116.3% | 267.4% | -80.2% | – |
| Cost of Goods Sold | $4 | $2 | $1 | $0 |
| Gross Profit | $3 | $1 | -$0 | $4 |
| % Margin | 44% | 36% | -3.5% | 96.5% |
| R&D Expenses | $0 | $0 | $1 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $9 | $7 | $10 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Expenses | $11 | $8 | $11 | $9 |
| Operating Income | -$8 | -$7 | -$11 | -$5 |
| % Margin | -124.4% | -224% | -1,292.5% | -125.4% |
| Other Income/Exp. Net | -$1 | -$1 | -$0 | -$1 |
| Pre-Tax Income | -$9 | -$8 | -$11 | -$7 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$9 | -$8 | -$11 | -$7 |
| % Margin | -139.3% | -266% | -1,324.8% | -160% |
| EPS | -30.19 | -5.131 | -8.985 | -6.259 |
| % Growth | -488.4% | 42.9% | -43.6% | – |
| EPS Diluted | -30.19 | -5.131 | -8.985 | -6.259 |
| Weighted Avg Shares Out | 0 | 3 | 2 | 2 |
| Weighted Avg Shares Out Dil | 0 | 3 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $1 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$7 | -$7 | -$11 | -$5 |
| % Margin | -109.4% | -227.8% | -1,307.8% | -125.4% |